BOSTON SCIENTIFIC CORPORATION (BSX) FY2025 Annual Balance Sheet

Balance Sheet

As of 2025-12-31

Swipe to see the full flow
BOSTON SCIENTIFIC CORPORATION (BSX) FY2025 Annual Balance SheetBalance sheet as of 2025-12-31. The chart shows assets, liabilities and equity at that date.Current liabilities$5.44 BLiabilities(calculated)$19.20 BCurrent assets$8.79 BNon-current liabilities$13.76 BAssets$43.67 BNon-current assets$34.88 BEquity$24.47 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSInventoriesTrade accounts receivable, netCash and cash equivalentsOther current assetsPrepaid income taxesGoodwillOther intangible assets, netProperty, plant and equipment, netDeferred tax assetsOther long-term assetsAccrued expensesAccounts payableOther current liabilitiesCurrent debt obligationsLong-term debtOther long-term liabilitiesDeferred tax liabilitiesAdditional paid-in capitalRetained earningsCommon stock, $0.01 par value - authorized 2,000,000,000 shares; 1,746,290,165 shares issued as of December 31, 2025 and 1,737,846,196 shares issued as of December 31, 2024Noncontrolling interestsTreasury stock, at cost - 263,289,848 shares as of December 31, 2025 and 2024Accumulated other comprehensive income (loss), net of taxCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilities (calculated)EquityAccrued expensesAccrued expenses$3.20 BCurrent liabilitiesCurrent liabilities$5.44 BAccounts payableAccounts payable$1.14 BLiabilities (calculated)Liabilities(calculated)$19.20 BOther current liabilitiesOther current liabilities$795.00 MInventoriesInventories$2.94 BCurrent debt obligationsCurrent debt obligations$299.00 MCurrent assetsCurrent assets$8.79 BTrade accounts receivable, netTrade accounts receivable, net$2.93 BNon-current liabilitiesNon-current liabilities$13.76 BCash and cash equivalentsCash and cash equivalents$1.97 BAssetsAssets$43.67 BLong-term debtLong-term debt$11.14 BOther current assetsOther current assets$660.00 MOther long-term liabilitiesOther long-term liabilities$2.41 BPrepaid income taxesPrepaid income taxes$299.00 MDeferred tax liabilitiesDeferred tax liabilities$220.00 MNon-current assetsNon-current assets$34.88 BGoodwillGoodwill$18.28 BEquityEquity$24.47 BAdditional paid-in capitalAdditional paid-in capital$21.51 BOther intangible assets, netOther intangible assets, net$7.02 BProperty, plant and equipment, netProperty, plant and equipment, net$4.04 BRetained earningsRetained earnings$5.57 BDeferred tax assetsDeferred tax assets$3.68 BCommon stock, $0.01 par value - authorized 2,000,000,000 shares; 1,746,290,165 shares issued as of December 31, 2025 and 1,737,846,196 shares issued as of December 31, 2024Common stock$17.00 MOther long-term assetsOther long-term assets$1.87 BNoncontrolling interestsNoncontrolling interests$239.00 MTreasury stock, at cost - 263,289,848 shares as of December 31, 2025 and 2024Treasury stock−$2.25 BAccumulated other comprehensive income (loss), net of taxAccumulated other comprehensive income (loss), net−$610.00 M
Chart details

BOSTON SCIENTIFIC CORPORATION (BSX) FY2025 Annual Balance Sheet

Balance sheet as of 2025-12-31. The chart shows assets, liabilities and equity at that date.

Assets
43,673,000,000 US dollars
Current assets
8,794,000,000 US dollars
Non-current assets
34,879,000,000 US dollars
Liabilities (calculated)
19,201,000,000 US dollars
Current liabilities
5,439,000,000 US dollars
Non-current liabilities
13,762,000,000 US dollars
Equity
24,472,000,000 US dollars
Noncontrolling interest
239,000,000 US dollars. Included in consolidated equity; this amount is not added again.
Inventories
2,943,000,000 US dollars
Trade accounts receivable, net
2,926,000,000 US dollars
Cash and cash equivalents
1,965,000,000 US dollars
Other current assets
660,000,000 US dollars
Prepaid income taxes
299,000,000 US dollars
Goodwill
18,282,000,000 US dollars
Other intangible assets, net
7,019,000,000 US dollars
Property, plant and equipment, net
4,036,000,000 US dollars
Deferred tax assets
3,675,000,000 US dollars
Other long-term assets
1,866,000,000 US dollars
Accrued expenses
3,201,000,000 US dollars
Accounts payable
1,144,000,000 US dollars
Other current liabilities
795,000,000 US dollars
Current debt obligations
299,000,000 US dollars
Long-term debt
11,137,000,000 US dollars
Other long-term liabilities
2,405,000,000 US dollars
Deferred tax liabilities
220,000,000 US dollars
Additional paid-in capital
21,505,000,000 US dollars
Retained earnings
5,571,000,000 US dollars
Common stock, $0.01 par value - authorized 2,000,000,000 shares; 1,746,290,165 shares issued as of December 31, 2025 and 1,737,846,196 shares issued as of December 31, 2024
17,000,000 US dollars
Preferred stock, $0.01 par value - authorized 50,000,000 shares; 0 shares issued as of December 31, 2025 and 2024
0 US dollars
Noncontrolling interests
239,000,000 US dollars
Treasury stock, at cost - 263,289,848 shares as of December 31, 2025 and 2024
negative 2,251,000,000 US dollars
Accumulated other comprehensive income (loss), net of tax
negative 610,000,000 US dollars

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
  • The filed current assets lines add up to $8,793.00 M and the current assets total is $8,794.00 M; the $1.00 M difference is within the rounding of the filed amounts.
  • The filed non-current assets lines add up to $34,878.00 M and the non-current assets total is $34,879.00 M; the $1.00 M difference is within the rounding of the filed amounts.
  • The filed equity lines add up to $24,471.00 M and the equity total is $24,472.00 M; the $1.00 M difference is within the rounding of the filed amounts.
BOSTON SCIENTIFIC CORPORATION (BSX) FY2025 Annual Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!